Allogeneic Hematopoietic Stem Cell Transplantation clinical trials

Explore recruiting allogeneic hematopoietic stem cell transplantation clinical trials.

Recruiting allogeneic hematopoietic stem cell transplantation studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Allogeneic Hematopoietic Stem Cell Transplantation trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

DK-CLIC-1901 CAR T-cells for treatment of patients with relapsed/refractory CD19 positive hematological malignancies (DAN-CART 1901)

Denmark

Therapeutic exploratory (Phase II) EU CTIS Study details

Magrolimab plus intensive chemotherapy in newly diagnosed “ELN intermediate or poor-risk” AML patients intended to undergo allogeneic stem cell transplantation, a Phase 2, Single-arm, Open-Label Study (MAGROLIC)

Germany

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase II randomized trial of RSV vaccination in allogeneic hematopoietic stem cell transplant recipients (RSV-Allo study)

Belgium

Phase II and Phase III (Integrated) EU CTIS Study details

Fecal Microbiota Transplantation in the prevention of complications after allogeneic hematopoietic stem cell transplantation for hematologic malignancy

France

Therapeutic exploratory (Phase II) EU CTIS Study details

Pharmacokinetics of anti-lymphocyte serum in the prevention of GvHD in children and adults receiving allogeneic hematopoietic stem cell transplantation - PHASAL-GA Study

France

Therapeutic use (Phase IV) EU CTIS Study details

VANCALLO - Prevention of C. difficile infections by oral vancomycin in patients treated for allogeneic hematopoietic stem cell transplantation, a randomized double-blind placebo-controlled trial

France

Therapeutic confirmatory (Phase III) EU CTIS Study details

Allogeneic Hematopoietic Stem Cell Transplantation trials by city

Allogeneic Hematopoietic Stem Cell Transplantation in Toronto Allogeneic Hematopoietic Stem Cell Transplantation in Vancouver Allogeneic Hematopoietic Stem Cell Transplantation in Montreal Allogeneic Hematopoietic Stem Cell Transplantation in Calgary Allogeneic Hematopoietic Stem Cell Transplantation in Edmonton Allogeneic Hematopoietic Stem Cell Transplantation in Ottawa Allogeneic Hematopoietic Stem Cell Transplantation in Winnipeg Allogeneic Hematopoietic Stem Cell Transplantation in Quebec City Allogeneic Hematopoietic Stem Cell Transplantation in Hamilton Allogeneic Hematopoietic Stem Cell Transplantation in Kitchener Allogeneic Hematopoietic Stem Cell Transplantation in London Allogeneic Hematopoietic Stem Cell Transplantation in Halifax Allogeneic Hematopoietic Stem Cell Transplantation in New York Allogeneic Hematopoietic Stem Cell Transplantation in Los Angeles Allogeneic Hematopoietic Stem Cell Transplantation in Chicago Allogeneic Hematopoietic Stem Cell Transplantation in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease